Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures

Journal of Neuroscience

Volumn 22, Issue 13, 2002, Pages 5403-5411

  Besong, Gilbert ^a   Battaglia, Giuseppe ^a   D'Onofrio, Mara ^a   Di Marco, Roberto ^b   Ngomba, Richard Teke ^a   Storto, Marianna ^a   Castiglione, Marzia ^c   Mangano, Katia ^b   Busceti, Carla L ^a   Bacon, Kevin ^d   Tusche, Michael ^d   Valenti, Ornella ^e   Conn, Peter Jeffrey ^e   Bruno, Valeria ^a,c   Nicoletti, F R ^a,b,c  

^a IRCCS NEUROMED   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d BAYER YAKUHIN LTD   (Japan)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokines; Experimental allergic encephalomyelitis; Glial cultures; Leukocytes; mGlu4 receptor; Multiple sclerosis

Indexed keywords

2 AMINO 4 PHOSPHONOBUTYRIC ACID; 4 PHOSPHONOPHENYLGLYCINE; ALPHA METHYLSERINE O PHOSPHATE; METABOTROPIC RECEPTOR; PERTUSSIS TOXIN; PHOSPHOSERINE; RANTES;

ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL CULTURE; CEREBELLUM; CULTURE MEDIUM; DIALYSATE; DISEASE SEVERITY; GLIA CELL; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OSMOTIC MINIPUMP; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; RAT; RAT STRAIN; SPINAL CORD; SYMPTOM;

EID: 0036662772     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-13-05403.2002     Document Type: Article

References (31)

1. Bacon KB, Oppenheim JJ (1998) Chemokines in disease models and pathogenesis. Cvtokine Growth Factor Rev 9:167-173.
2. Bacon KB, Premack BA, Gardner P, Schall TJ (1995) Activation of dual T cell signalling pathways by the chemokine RANTES. Science 269:1727-1730.
3. Barnes DA, Huston M, Holmes R, Benveniste EN, Yong VW, Scholz P, Perez HD (1996) Induction of RANTES expression by astrocytes and astrocytoma cell lines. J Neuroimmunol 71:207-214.
4. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Shall TJ (1997) A new class of membrane-bound chemokine with CX3C motif. Nature 385:640-644.
5. Bradley SR, Levey AI, Hersch SM, Conn PJ (1996) Immunocytochemical localization of group III metabotropic glutamate receptors in the hippocampus with subtype-specific antibodies. J Neurosci 16:2044-2056.
6. Bradley SR, Standaert DG, Rhodes KJ, Rees HD, Testa CM, Levey AI, Conn PJ (1999) Immunoistochemical localization of subtype 4a metabotropic glutamate receptors in the rat and mouse ganglia. J Comp Neurol 407:33-46.
7. Ciccarelli R, Di Iorio P, Bruno V, Battaglia G, D'alimonte G, D'Onofrio M, Nicoletti F, Caciagli F (1999) Activation of A1 adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100β protein from cultured astrocytes. Glia 27:275-281.
8. Ciccarelli R, Di Iorio P, D'Alimonte I, Giuliani P, Florio T, Caciagli F, Middlemiss PJ, Rathbone MP (2000) Cultured astrocyte proliferation induced by extracellular guanosine involves endogenous adenosine and is raised by the co-presence of microglia. Gila 29:202-211.
9. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
10. Di Marco R, Khademi M, Wallstrom E, Iacobaeus E, Salvaggio A, Caracappa S, Papoian R, Nicoletti F, Olsson T (2001) Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis. J Neuroimmunol 116:168-177.
11. Glabinski AR, Tuohy VK, Ransohoff RM (1998) Expression of chemokines RANTES, MIP-1 alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis. Neuroimmunomodulation 5:166-171.
12. Godiska R, Chantry D, Dietsch GN, Gray PW (1995) Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol 58:167-176.
13. Iarlori C, Reale M, Lugaresi A, De Luca G, Bonanni L, Di Iorio A, Feliciani C, Conti P, Gambi D (2000) RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-lb. J Neuroimmunol 107:100-107.
14. Mennicken F, Maki R, de Souza EB, Quirion R (1999) Chemokines and chemokine receptors in the CNS: A possible role in neuroinflammation and patterning. Trends Pharmacol Sci 20:73-77.
15. Miller S, Romano C, Cotman CW (1995) Growth factor upregulation of a phosphoinositide-coupled metabotropic glutamate receptor in cortical astrocytes. J Neurosci 15:6103-6109.
16. Miyagishi R, Kikuchi S, Takayama C, Inoue Y, Tashiro K (1997) Identification of cell types producing RANTES, MIP-1 α and MIP-1 β in rat experimental autoimmune encephalomyelitis by in situ hybridization. J Neuroimmunol 77:17-26.
17. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA, Vath J, Gosselin M, Ma J, Dussault B, Woolf E, Alperin J, Culpepper J, Gultierrez-Ramos JC, Gearing D (1997) Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387:611-617.
18. PelIegrino JL, Pellegrino SA, Cushman JA (1992) A Stereotaxic Atlas of the Rat Brain. New York: Plenum.
19. Perry VH, Anthony DC, Bolton SJ, Brown HC (1997) The blood-brain barrier and the inflammatory response. Mol Med Today 3:335-341.
20. Petralia RS, Wang W-X, Niedzielski AS, Wenthold RJ (1996) The metabotropic glutamate receptors mGluR2 and mGluR3 show unique postsynaptic, presynaptic and glial localization. Neuroscience 71:949-976.
21. Pin JP, Duvoisin R (1995) The metabotropic glutamate receptors: Structure and functions. Neuropharmacology 34:1-26.
22. Ransohoff RM (1999) Mechanism of inflammation in MS tissue: Adhesion molecules and chemokines. J Neuroimmunol 98:57-68.
23. Ransohoff RM, Bacon KB (2000) Chemokine receptor antagonism as a new therapy for multiple sclerosis. Exp Opin Invest Drugs 9:1079-1096.
24. Rose K, Goldberg MP, Choi DW (1992) Cytotoxicity in murine neocortical cell culture. Methods Toxicol 1:46-60.
25. Schall TJ, Bacon K, Toy KJ, Goeddel DV (1990) Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 374:669-671.
26. Schoepp DD, Jane DE, Monn JA (1999) Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38:1431-1476.
27. Simpson JE, Newcombe J, Cuzner ML, Woodrofe MN (1998) Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol 84:238-249.
28. Sorensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottmann J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103:807-815.
29. Taub DD, Sayer TJ, Carter CR, Ortaldo JR (1995) Alpha and beta chemokines induced NK cell migration and enhance NK-mediated cytolysis. J Immunol 155:3877-3888.
30. Wells TNC, Power CA, Proudfoot AET (1998) Definition, function and pathophysiological significance of chemokine receptors. Trends Pharmacol Sci 19:376-380.
31. Zang YC, Halder JB, Samanta AK, Hong J, Rivera VM, Zhang JZ (2001) Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1 alpha by interferon-beta. J Neuroimmunol 112:172-180.